From TokenPost · · 40s
Alnylam Q3 Revenue Rises 17%
Alnylam's Q3 revenue jumps 17% to $1.46 billion as net product revenue surges 52%.
In brief
Alnylam's Q3 revenue jumps 17% to $1.46 billion as net product revenue surges 52%. Alnylam Pharmaceuticals reported $1.458 billion Q3 revenue, a 17% year-over-year increase, with net product revenue up 52% to $1.292 billion. Originally reported by TokenPost.
Alnylam Q3 Revenue
Alnylam Pharmaceuticals recorded $1.458 billion in revenue for the quarter ended Sept. 30, a 17% increase from a year earlier.
Net Product Revenue Jump
Net product revenue climbed 52% to $1.292 billion, while diluted non-GAAP earnings per share reached $16.26.
2026 Revenue Forecast
Alnylam reaffirmed its 2026 forecast for total net product revenue of $4.7 billion to $5.1 billion.
The headline
Alnylam Pharmaceuticals reported $1.458 billion Q3 revenue, a 17% year-over-year increase, with net product revenue up 52% to $1.292 billion.
